Global Remicade (infliximab) Drug Market Research Report 2023

Report ID: 1897672 | Published Date: Oct 2024 | No. of Page: 88 | Base Year: 2023 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Remicade (infliximab) Drug Market Overview
    1.1 Product Overview and Scope of Remicade (infliximab) Drug
    1.2 Remicade (infliximab) Drug Segment by Type
        1.2.1 Global Remicade (infliximab) Drug Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Brands Drugs
        1.2.3 Generic Drugs
    1.3 Remicade (infliximab) Drug Segment by Application
        1.3.1 Global Remicade (infliximab) Drug Sales Comparison by Application: (2022-2028)
        1.3.2 Crohn's Disease
        1.3.3 Pediatric Crohn's Disease
        1.3.4 Ulcerative Colitis
        1.3.5 Pediatric Ulcerative Colitis
        1.3.6 Other
    1.4 Global Remicade (infliximab) Drug Market Size Estimates and Forecasts
        1.4.1 Global Remicade (infliximab) Drug Revenue 2017-2028
        1.4.2 Global Remicade (infliximab) Drug Sales 2017-2028
        1.4.3 Remicade (infliximab) Drug Market Size by Region: 2017 Versus 2021 Versus 2028
2 Remicade (infliximab) Drug Market Competition by Manufacturers
    2.1 Global Remicade (infliximab) Drug Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Remicade (infliximab) Drug Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Remicade (infliximab) Drug Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Remicade (infliximab) Drug Manufacturing Sites, Area Served, Product Type
    2.5 Remicade (infliximab) Drug Market Competitive Situation and Trends
        2.5.1 Remicade (infliximab) Drug Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Remicade (infliximab) Drug Players Market Share by Revenue
        2.5.3 Global Remicade (infliximab) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Remicade (infliximab) Drug Retrospective Market Scenario by Region
    3.1 Global Remicade (infliximab) Drug Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Remicade (infliximab) Drug Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Remicade (infliximab) Drug Market Facts & Figures by Country
        3.3.1 North America Remicade (infliximab) Drug Sales by Country
        3.3.2 North America Remicade (infliximab) Drug Revenue by Country
        3.3.3 the United States
        3.3.4 Canada
    3.4 Europe Remicade (infliximab) Drug Market Facts & Figures by Country
        3.4.1 Europe Remicade (infliximab) Drug Sales by Country
        3.4.2 Europe Remicade (infliximab) Drug Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 UK
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Remicade (infliximab) Drug Market Facts & Figures by Region
        3.5.1 Asia Pacific Remicade (infliximab) Drug Sales by Region
        3.5.2 Asia Pacific Remicade (infliximab) Drug Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Remicade (infliximab) Drug Market Facts & Figures by Country
        3.6.1 Latin America Remicade (infliximab) Drug Sales by Country
        3.6.2 Latin America Remicade (infliximab) Drug Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Remicade (infliximab) Drug Market Facts & Figures by Country
        3.7.1 Middle East and Africa Remicade (infliximab) Drug Sales by Country
        3.7.2 Middle East and Africa Remicade (infliximab) Drug Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Remicade (infliximab) Drug Historic Market Analysis by Type
    4.1 Global Remicade (infliximab) Drug Sales Market Share by Type (2017-2022)
    4.2 Global Remicade (infliximab) Drug Revenue Market Share by Type (2017-2022)
    4.3 Global Remicade (infliximab) Drug Price by Type (2017-2022)
5 Global Remicade (infliximab) Drug Historic Market Analysis by Application
    5.1 Global Remicade (infliximab) Drug Sales Market Share by Application (2017-2022)
    5.2 Global Remicade (infliximab) Drug Revenue Market Share by Application (2017-2022)
    5.3 Global Remicade (infliximab) Drug Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Janssen
        6.1.1 Janssen Corporation Information
        6.1.2 Janssen Description and Business Overview
        6.1.3 Janssen Remicade (infliximab) Drug Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Janssen Remicade (infliximab) Drug Product Portfolio
        6.1.5 Janssen Recent Developments/Updates
    6.2 Hospira
        6.2.1 Hospira Corporation Information
        6.2.2 Hospira Description and Business Overview
        6.2.3 Hospira Remicade (infliximab) Drug Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Hospira Remicade (infliximab) Drug Product Portfolio
        6.2.5 Hospira Recent Developments/Updates
    6.3 Celltrion Healthcare
        6.3.1 Celltrion Healthcare Corporation Information
        6.3.2 Celltrion Healthcare Description and Business Overview
        6.3.3 Celltrion Healthcare Remicade (infliximab) Drug Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Celltrion Healthcare Remicade (infliximab) Drug Product Portfolio
        6.3.5 Celltrion Healthcare Recent Developments/Updates
    6.4 Epirus Biopharmaceuticals
        6.4.1 Epirus Biopharmaceuticals Corporation Information
        6.4.2 Epirus Biopharmaceuticals Description and Business Overview
        6.4.3 Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Epirus Biopharmaceuticals Remicade (infliximab) Drug Product Portfolio
        6.4.5 Epirus Biopharmaceuticals Recent Developments/Updates
    6.5 Samsung Bioepsis
        6.5.1 Samsung Bioepsis Corporation Information
        6.5.2 Samsung Bioepsis Description and Business Overview
        6.5.3 Samsung Bioepsis Remicade (infliximab) Drug Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Samsung Bioepsis Remicade (infliximab) Drug Product Portfolio
        6.5.5 Samsung Bioepsis Recent Developments/Updates
7 Remicade (infliximab) Drug Manufacturing Cost Analysis
    7.1 Remicade (infliximab) Drug Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Remicade (infliximab) Drug
    7.4 Remicade (infliximab) Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Remicade (infliximab) Drug Distributors List
    8.3 Remicade (infliximab) Drug Customers
9 Remicade (infliximab) Drug Market Dynamics
    9.1 Remicade (infliximab) Drug Industry Trends
    9.2 Remicade (infliximab) Drug Market Drivers
    9.3 Remicade (infliximab) Drug Market Challenges
    9.4 Remicade (infliximab) Drug Market Restraints
10 Global Market Forecast
    10.1 Remicade (infliximab) Drug Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Remicade (infliximab) Drug by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Remicade (infliximab) Drug by Type (2023-2028)
    10.2 Remicade (infliximab) Drug Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Remicade (infliximab) Drug by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Remicade (infliximab) Drug by Application (2023-2028)
    10.3 Remicade (infliximab) Drug Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Remicade (infliximab) Drug by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Remicade (infliximab) Drug by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Remicade (infliximab) Drug Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Remicade (infliximab) Drug Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Remicade (infliximab) Drug Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Remicade (infliximab) Drug Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Remicade (infliximab) Drug Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Remicade (infliximab) Drug Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Remicade (infliximab) Drug Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Remicade (infliximab) Drug Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Remicade (infliximab) Drug Average Price (USD/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Remicade (infliximab) Drug Manufacturing Sites and Area Served
    Table 11. Manufacturers Remicade (infliximab) Drug Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Remicade (infliximab) Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Remicade (infliximab) Drug as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Remicade (infliximab) Drug Sales by Region (2017-2022) & (K Units)
    Table 16. Global Remicade (infliximab) Drug Sales Market Share by Region (2017-2022)
    Table 17. Global Remicade (infliximab) Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Remicade (infliximab) Drug Revenue Market Share by Region (2017-2022)
    Table 19. North America Remicade (infliximab) Drug Sales by Country (2017-2022) & (K Units)
    Table 20. North America Remicade (infliximab) Drug Sales Market Share by Country (2017-2022)
    Table 21. North America Remicade (infliximab) Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Remicade (infliximab) Drug Revenue Market Share by Country (2017-2022)
    Table 23. Europe Remicade (infliximab) Drug Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Remicade (infliximab) Drug Sales Market Share by Country (2017-2022)
    Table 25. Europe Remicade (infliximab) Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Remicade (infliximab) Drug Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Remicade (infliximab) Drug Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Remicade (infliximab) Drug Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Remicade (infliximab) Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Remicade (infliximab) Drug Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Remicade (infliximab) Drug Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Remicade (infliximab) Drug Sales Market Share by Country (2017-2022)
    Table 33. Latin America Remicade (infliximab) Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Remicade (infliximab) Drug Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Remicade (infliximab) Drug Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Remicade (infliximab) Drug Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Remicade (infliximab) Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Remicade (infliximab) Drug Revenue Market Share by Country (2017-2022)
    Table 39. Global Remicade (infliximab) Drug Sales by Type (2017-2022) & (K Units)
    Table 40. Global Remicade (infliximab) Drug Sales Market Share by Type (2017-2022)
    Table 41. Global Remicade (infliximab) Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Remicade (infliximab) Drug Revenue Share by Type (2017-2022)
    Table 43. Global Remicade (infliximab) Drug Price by Type (2017-2022) & (USD/Unit)
    Table 44. Global Remicade (infliximab) Drug Sales (K Units) by Application (2017-2022)
    Table 45. Global Remicade (infliximab) Drug Sales Market Share by Application (2017-2022)
    Table 46. Global Remicade (infliximab) Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Remicade (infliximab) Drug Revenue Share by Application (2017-2022)
    Table 48. Global Remicade (infliximab) Drug Price by Application (2017-2022) & (USD/Unit)
    Table 49. Janssen Corporation Information
    Table 50. Janssen Description and Business Overview
    Table 51. Janssen Remicade (infliximab) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 52. Janssen Remicade (infliximab) Drug Product
    Table 53. Janssen Recent Developments/Updates
    Table 54. Hospira Corporation Information
    Table 55. Hospira Description and Business Overview
    Table 56. Hospira Remicade (infliximab) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 57. Hospira Remicade (infliximab) Drug Product
    Table 58. Hospira Recent Developments/Updates
    Table 59. Celltrion Healthcare Corporation Information
    Table 60. Celltrion Healthcare Description and Business Overview
    Table 61. Celltrion Healthcare Remicade (infliximab) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 62. Celltrion Healthcare Remicade (infliximab) Drug Product
    Table 63. Celltrion Healthcare Recent Developments/Updates
    Table 64. Epirus Biopharmaceuticals Corporation Information
    Table 65. Epirus Biopharmaceuticals Description and Business Overview
    Table 66. Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 67. Epirus Biopharmaceuticals Remicade (infliximab) Drug Product
    Table 68. Epirus Biopharmaceuticals Recent Developments/Updates
    Table 69. Samsung Bioepsis Corporation Information
    Table 70. Samsung Bioepsis Description and Business Overview
    Table 71. Samsung Bioepsis Remicade (infliximab) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 72. Samsung Bioepsis Remicade (infliximab) Drug Product
    Table 73. Samsung Bioepsis Recent Developments/Updates
    Table 74. Production Base and Market Concentration Rate of Raw Material
    Table 75. Key Suppliers of Raw Materials
    Table 76. Remicade (infliximab) Drug Distributors List
    Table 77. Remicade (infliximab) Drug Customers List
    Table 78. Remicade (infliximab) Drug Market Trends
    Table 79. Remicade (infliximab) Drug Market Drivers
    Table 80. Remicade (infliximab) Drug Market Challenges
    Table 81. Remicade (infliximab) Drug Market Restraints
    Table 82. Global Remicade (infliximab) Drug Sales Forecast by Type (2023-2028) & (K Units)
    Table 83. Global Remicade (infliximab) Drug Sales Market Share Forecast by Type (2023-2028)
    Table 84. Global Remicade (infliximab) Drug Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 85. Global Remicade (infliximab) Drug Revenue Market Share Forecast by Type (2023-2028)
    Table 86. Global Remicade (infliximab) Drug Sales Forecast by Application (2023-2028) & (K Units)
    Table 87. Global Remicade (infliximab) Drug Sales Market Share Forecast by Application (2023-2028)
    Table 88. Global Remicade (infliximab) Drug Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 89. Global Remicade (infliximab) Drug Revenue Market Share Forecast by Application (2023-2028)
    Table 90. Global Remicade (infliximab) Drug Sales Forecast by Region (2023-2028) & (K Units)
    Table 91. Global Remicade (infliximab) Drug Sales Market Share Forecast by Region (2023-2028)
    Table 92. Global Remicade (infliximab) Drug Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 93. Global Remicade (infliximab) Drug Revenue Market Share Forecast by Region (2023-2028)
    Table 94. Research Programs/Design for This Report
    Table 95. Key Data Information from Secondary Sources
    Table 96. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Remicade (infliximab) Drug
    Figure 2. Global Remicade (infliximab) Drug Market Share by Type in 2021 & 2028
    Figure 3. Brands Drugs Product Picture
    Figure 4. Generic Drugs Product Picture
    Figure 5. Global Remicade (infliximab) Drug Market Share by Application in 2021 & 2028
    Figure 6. Crohn's Disease
    Figure 7. Pediatric Crohn's Disease
    Figure 8. Ulcerative Colitis
    Figure 9. Pediatric Ulcerative Colitis
    Figure 10. Other
    Figure 11. Global Remicade (infliximab) Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Remicade (infliximab) Drug Market Size (2017-2028) & (US$ Million)
    Figure 13. Global Remicade (infliximab) Drug Sales (2017-2028) & (K Units)
    Figure 14. Remicade (infliximab) Drug Sales Share by Manufacturers in 2021
    Figure 15. Global Remicade (infliximab) Drug Revenue Share by Manufacturers in 2021
    Figure 16. The Global 5 and 10 Largest Remicade (infliximab) Drug Players: Market Share by Revenue in 2021
    Figure 17. Remicade (infliximab) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 18. Global Remicade (infliximab) Drug Sales Market Share by Region (2017-2022)
    Figure 19. Global Remicade (infliximab) Drug Sales Market Share by Region in 2021
    Figure 20. Global Remicade (infliximab) Drug Revenue Market Share by Region (2017-2022)
    Figure 21. Global Remicade (infliximab) Drug Revenue Market Share by Region in 2021
    Figure 22. the United States Remicade (infliximab) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. Canada Remicade (infliximab) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Germany Remicade (infliximab) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. France Remicade (infliximab) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. UK Remicade (infliximab) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Italy Remicade (infliximab) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Russia Remicade (infliximab) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. China Remicade (infliximab) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Japan Remicade (infliximab) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. South Korea Remicade (infliximab) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. India Remicade (infliximab) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Australia Remicade (infliximab) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. China Taiwan Remicade (infliximab) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Indonesia Remicade (infliximab) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Thailand Remicade (infliximab) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Malaysia Remicade (infliximab) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Mexico Remicade (infliximab) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Brazil Remicade (infliximab) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Argentina Remicade (infliximab) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Turkey Remicade (infliximab) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Saudi Arabia Remicade (infliximab) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. UAE Remicade (infliximab) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Sales Market Share of Remicade (infliximab) Drug by Type (2017-2022)
    Figure 45. Manufacturing Cost Structure of Remicade (infliximab) Drug
    Figure 46. Manufacturing Process Analysis of Remicade (infliximab) Drug
    Figure 47. Remicade (infliximab) Drug Industrial Chain Analysis
    Figure 48. Channels of Distribution
    Figure 49. Distributors Profiles
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Janssen
Hospira
Celltrion Healthcare
Epirus Biopharmaceuticals
Samsung Bioepsis
Frequently Asked Questions
Remicade (infliximab) Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Remicade (infliximab) Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Remicade (infliximab) Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Soliris Drug

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More